GeneDx Holdings Corp. (WGS) — Stock Score Summary

GeneDx Holdings Corp. (WGS) has a MoatMap StockRank of 16/100 based on Quality (44/100), Value (38/100), and Momentum (19/100) factor scores. The current signal is STRONG SELL. GeneDx is a genomic diagnostics company. While it has high growth potential, it is currently unprofitable and operates in a highly capital-intensive, regulatory-heavy sector that does not yet meet our quality compounder criteria.

GeneDx Holdings Corp. is a leader in clinical genomics, specializing in exome and genome sequencing to diagnose rare diseases and pediatric disorders. The company's competitive moat is anchored by its massive proprietary genomic database and advanced clinical interpretation engine. It operates as a premier diagnostic player at the forefront of precision medicine.

Key Financial Metrics

Price$52.36
Market Cap$1.5B
P/E (Forward)45.70
Price/Book5.34
Return on Equity-30.4%
Return on Invested Capital-3.2%
Debt/Equity66.19
Gross Margin69.6%
Operating Margin-25.6%
Revenue Growth17.4%
Free Cash Flow$4M

GeneDx Holdings Corp. operates in the Diagnostics & Research industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is GeneDx Holdings Corp.’s (WGS) StockRank?
MoatMap’s StockRank for GeneDx Holdings Corp. (WGS) is 16/100, with a Strong Sell signal. It is a composite of Quality (44), Value (38), and Momentum (19) factor ranks across MoatMap’s 19,000+ stock universe.
Does GeneDx Holdings Corp. have an economic moat?
GeneDx Holdings Corp. (WGS) has a Quality factor score of 44/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is GeneDx Holdings Corp. a buy, hold, or sell?
MoatMap’s current signal for GeneDx Holdings Corp. (WGS) is Strong Sell, based on a StockRank of 16/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is GeneDx Holdings Corp. in?
GeneDx Holdings Corp. (WGS) operates in the Healthcare sector, specifically the Diagnostics & Research industry (United States).
Browse all ranked stocksWGS deep dive reportAI ChampionsHow we score stocksSense-check another stock